American Century Companies’s ESSA Pharma EPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-46,373
Closed -$78.8K 2813
2025
Q2
$78.8K Hold
46,373
﹤0.01% 2805
2025
Q1
$73.3K Hold
46,373
﹤0.01% 2847
2024
Q4
$83K Sell
46,373
-279
-0.6% -$889 ﹤0.01% 2851
2024
Q3
$283K Sell
46,652
-96
-0.2% -$527 ﹤0.01% 2668
2024
Q2
$246K Buy
46,748
+572
+1% +$3.64K ﹤0.01% 2690
2024
Q1
$392K Buy
46,176
+26,132
+130% +$228K ﹤0.01% 2535
2023
Q4
$132K Buy
+20,044
New +$98.7K ﹤0.01% 2773

Other funds holding EPIX

American Century Companies's EPIX Position: Q3 2025 in Review

American Century Companies sold out of ESSA Pharma (EPIX) in Q3 2025, closing a stake of 46,373 shares — an estimated $78.8K sold.

American Century Companies first reported a position in EPIX in Q4 2023 and held it in 7 quarters. The position peaked at $392K in Q1 2024. 32 funds tracked by Wall St. Rank hold EPIX as of Q3 2025.

  • American Century Companies reported no remaining ESSA Pharma position as of Q3 2025 after selling out during the quarter.
  • American Century Companies sold 46,373 ESSA Pharma shares in Q3 2025, an estimated $78.8K.
  • American Century Companies first reported a position in ESSA Pharma in Q4 2023 and held it in 7 quarters.
  • American Century Companies's ESSA Pharma position peaked at $392K in Q1 2024.
  • 32 funds tracked by Wall St. Rank held ESSA Pharma as of Q3 2025.

Based on American Century Companies's 13F filing for Q3 2025, filed 12 Nov 2025.